UV Clinical A/S
CVR 38401572 · Public limited company (A/S) · Active · Low risk
UV Clinical A/S is a Public limited company (A/S), founded on , based in Hellerup. The company is registered in the industry fremstilling af medicinske og dentale instrumenter samt udstyr hertil. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 9 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 22.8m and a net result of DKK -1.3m. CEO: Rolf Henrik Sprunk-Jansen.
Bankruptcy risk for UV Clinical A/S
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38401572
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (9 years)
- Address
- Strandvejen 100
2900 Hellerup - Municipality
- Gentofte
- Industry
- Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)
Bankruptcies in the industry: Fremstilling af medicinske og dentale instrumenter samt udstyr hertil - Share capital
- DKK 904k
- Employees
- 1 (2018)
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 9 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 67.5% |
| Current ratio | 115% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 282 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 1.3m | DKK 333k |
| Net profit | DKK -1.3m | DKK -1.9m |
| Equity | DKK 22.8m | DKK 20.1m |
| Total assets | DKK 33.8m | DKK 23.0m |
| Cash | DKK 5.4m | – |
| Short-term debt | DKK 7.9m | – |
| Avg. employees | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 179 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 87 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 241 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 149 | ||
| 1 Feb 2017 – 31 Dec 2017 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Rolf Henrik Sprunk-Jansen | Current | |
| CEO | Leif Helth Jensen | ||
| CEO | Jimmy Bak | ||
| Board | Rolf Henrik Sprunk-Jansen | Current | |
| Board | Helge Holm-Larsen | Current | |
| Board | Emilio de la Guardia Gascuñana | Current | |
| Board | Gustaf Iuel-Brockdorff | ||
| Board | Leif Helth Jensen | ||
| Board | Jimmy Bak | ||
| Board | Anne Sophie Winther Hansen | ||
| Board | Helge Holm-Larsen | ||
| Board | Brian Schebye | ||
| Board | Jan Friis Schack | ||
| Board | Claus Frisenberg Pedersen | ||
| Board | Carsten Viftrup Andersen | ||
| Board | Jimmy Bak | ||
| Owner (25%) | Canajo Invest ApS | Current | |
| Owner (15%) | Ulstrup Invest ApS | Current | |
| Owner (5%) | Holafa ApS | Current | |
| Owner (25%) | Leif Helth Jensen | ||
| Owner (50%) | Jimmy Bak | ||
| Owner (20%) | Styrelsen for Forskning og Uddannelse | ||
| Owner (20%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (20%) | Leif Helth Jensen | ||
| Owner (33%) | Jimmy Bak | ||
| Owner (100%) | Jimmy Bak | ||
| Owner (20%) | Jimmy Bak | ||
| Owner (67%) | Canajo Invest ApS | ||
| Owner (50%) | Canajo Invest ApS | ||
| Owner (20%) | Holafa ApS | ||
| Owner (15%) | Jimmy Bak | ||
| Owner (10%) | Ulstrup Invest ApS | ||
| Owner (15%) | Holafa ApS | ||
| Owner (10%) | Jimmy Bak | ||
| Owner (15%) | Ulstrup Invest ApS | ||
| Owner (33%) | Canajo Invest ApS | ||
| Owner (10%) | Holafa ApS | ||
| Owner (10%) | Ulstrup Invest ApS | ||
| Owner (10%) | Jimmy Bak | ||
| Owner (10%) | Holafa ApS | ||
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Leif Helth Jensen | Current | |
| Founder | Jimmy Bak | Current |
The CEOs' other companies
Rolf Henrik Sprunk-Jansen – 12 other companies, of which 7 bankrupt
- ANPARTSSELSKABET AF 10.7.2010 Bankrupt 27 Nov 2012
- BALDER REVISION ApS Bankrupt 20 Nov 2012
- LAROMINI ApS Bankrupt 6 Mar 2026
- LED Aviation A/S Bankrupt 10 Mar 2026
- NLR Invest ApS Bankrupt 1 Jul 2026
- Nordrion III ApS Bankrupt 6 Apr 2022
- SPRUNK-JANSEN A/S Bankrupt 30 Nov 2010
- Green Technology Investment ApS Active
- LAROMINI ApS Fusioneret
- LED Livestock ApS Opløst
- LED VirusKill A/S Opløst
- TRIFIRE ApS Active
Leif Helth Jensen – 35 other companies, of which 5 bankrupt
- ALCORLAB A/S Bankrupt 1 Dec 2010
- BLUSENSE DIAGNOSTICS APS Bankrupt 24 May 2023
- HEED DIAGNOSTICS ApS Bankrupt 15 Apr 2016
- MEDITEL A/S Bankrupt 24 May 2000
- SUPER ApS Bankrupt 19 Jan 2016
- Blue Cell Therapeutics ApS Active
- CRITHERAPY ApS Compulsorily dissolved
- CUREON A/S Fusioneret
- DENCORE ApS Fusioneret
- DENTOFIT A/S Opløst
- DRUGRECURE ApS Active
- EXIQON A/S Fusioneret
- Endothel Pharma ApS Active
- GENMAB A/S Active
- GLOBAL AVIATION DATA A/S Active
- HYGIA DIAGNOSTICS ApS Opløst
- INAGEN ApS Opløst
- LEIF HELTH CARE A/S Opløst
- Loma Therapeutics ApS Active
- MICROLYTIC ApS Opløst
- Migalis ApS Active
- NORDIC PATENT SERVICE A/S Active
- NSE ApS Opløst
- OLDBAK ApS Active
- PHARMAORIGIN ApS Active
- PROFOUND INVEST A/S Opløst
- PROMOGENETICS ApS Opløst
- ROSE PHARMA A/S Compulsorily dissolved
- SECURIN ApS Active
- Serenova A/S Opløst
Jimmy Bak – 1 other companies
- U-VIVO ApS Opløst
Address history (2 moves)
| Strandvejen 100, 2900 Hellerup | |
| Diplomvej 381, 2800 Kongens Lyngby | |
| c/o Jimmy Bak, Solbakken 16, 2670 Greve |
Former names
| UV Clinical A/S | – now |
| UV Clinical ApS | – |
Employees per year
Other companies at the same address
- 2951 ApS Bankrupt
- 2M INVEST A/S Bankrupt
- 2M SERVICES A/S Bankrupt
- 4YOU ApS Bankrupt
- A/S 29 42 05 48 Bankrupt
- AA BRAND TRADING ApS Bankrupt
- AA FOOD SUPPLY ApS Bankrupt
- AGGRIT A/S Bankrupt
- ANPARTSSELSKABET AF 10.7.2010 Bankrupt
- AP213 ApS Bankrupt
- AP224 ApS Bankrupt
- AQUAMENT HOLDING ApS Bankrupt
- ATHENEFLYT ApS Bankrupt
- Andersen Academy IVS Bankrupt
- Asiana Marketing Services ApS Bankrupt
- B. H. THOMSEN TRADING IVS Bankrupt
- BALDER MANAGEMENT ApS Bankrupt
- BARKHILL GROUP DENMARK ApS Bankrupt
- BJERRE & KJÆR BYG ApS Bankrupt
- BJERRE & KJÆR GRUPPEN HOLDING ApS Bankrupt
- BK BYGGEINDUSTRI ApS Bankrupt
- Baltic Holding ApS Bankrupt
- BØG INVEST 1 ApS Bankrupt
- BØG INVEST 2 ApS Bankrupt
- CASA SOLA A/S Bankrupt
Similar companies in Gentofte
- Selskabet af 04.12.2009 ApS Hellerup
- Copenhagen Candle Lab IVS Gentofte
- CATO PHARMA ApS Hellerup
- KANEL ApS Gentofte
- AURUMANIA ApS Hellerup
- SALKMN 181 ApS Charlottenlund
- TEMPONOVA ApS Klampenborg
Questions and answers about UV Clinical A/S
Has UV Clinical A/S gone bankrupt?
No, UV Clinical A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of UV Clinical A/S?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of UV Clinical A/S?
Rolf Henrik Sprunk-Jansen is the CEO of UV Clinical A/S.
Who is the auditor of UV Clinical A/S?
UV Clinical A/S most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was UV Clinical A/S founded?
UV Clinical A/S was founded on 1 February 2017.
What is the equity of UV Clinical A/S?
Equity was DKK 22.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.